Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Larry K Kvols"'
Publikováno v:
Canadian Journal of Gastroenterology, Vol 21, Iss 2, Pp 113-115 (2007)
A 43-year-old man with a history of metastatic carcinoid disease is presented. The patient had symptoms of chronic intermittent abdominal pain two years after undergoing a wireless capsule endoscopy procedure. Radiological examinations revealed a ret
Externí odkaz:
https://doaj.org/article/44f6465b08444e258afff702d2572d5b
Autor:
Alan R. Gintzler, Zsolt Liposits, Annie Rodolosse, Stefano Partelli, Karl J. Iremonger, Tobias Keck, Eric Van Cutsem, Dagmar Führer-Sakel, Herbert Auer, Adil Al-Nahhas, Sture Holm, Csaba Vastagh, Miklós Sárvári, Sonja Siegel, Emiliya M. Storman, Michael Buchfelder, Martyn Caplin, Norbert Solymosi, Giuseppe Fusai, John Martin, Bernadette Kleist, Massimo Falconi, Juergen Honegger, John D. Hainsworth, Volker Fendrich, James C. Yao, Ilonka Kreitschmann-Andermahr, Imre Farkas, Marianne Pavel, Monika Milian, Roberto Valente, Panagiotis Drymousis, Allan E. Herbison, Domenico Tamburrino, Larry K. Kvols, Tsambika Psaras, Druckerei Stückle, Andrea Frilling, Christina Thirlwell, Lowell B. Anthony, Scott Segal, Arjun Kumar, Nai-Jiang Liu, Ashley K Clift, Harpreet Wasan, Susan L. Samson, Marco Inama, Satz Mengensatzproduktion, Detlef K. Bartsch, Nehara Begum, Dieter Hörsch, Anja Rinke, Kjell Öberg
Publikováno v:
Neuroendocrinology. 102:169-176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114f1af35812b4f5f9eb166ed652b687
https://doi.org/10.1159/000435895
https://doi.org/10.1159/000435895
Autor:
Jennifer A. Chan, Larry K. Kvols, Tiffany Campos, Matthew H. Kulke, Thomas A. Abrams, Jeffrey A. Meyerhardt, Jill Weber, Jonathan R. Strosberg, Eileen Regan, Charles S. Fuchs, Rachel Brady, David P. Ryan
Publikováno v:
Endocrine-Related Cancer. 20:383-390
The IGF pathway has been implicated in the regulation of neuroendocrine tumor (NET) growth, and preliminary studies suggested that ganitumab (AMG 479), a human MAB against IGF1R, may have antitumor activity in this setting. We performed a two-cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4c1ce9196a4306eb7def0ad97a3785
https://doi.org/10.1530/erc-12-0390
https://doi.org/10.1530/erc-12-0390
Autor:
Jill Weber, Domenico Coppola, Larry K. Kvols, Max Feldman, Jonathan R. Strosberg, Kenneth L. Meredith
Publikováno v:
Journal of Clinical Oncology. 31:420-425
Purpose The American Joint Committee on Cancer (AJCC) staging manual has introduced a TNM staging classification for jejunal-ileal (midgut) neuroendocrine tumors (NETs). This classification has not been validated in a population consisting solely of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f59a945805d61afa470363b5a82de355
https://doi.org/10.1200/jco.2012.44.5924
https://doi.org/10.1200/jco.2012.44.5924
Publikováno v:
Neuroendocrinology. 97:318-321
Background: Metastatic neuroendocrine tumors of the thymus are exceedingly rare with an annual incidence of approximately 0.2 per 1,000,000. They are highly resistant to therapy and there have been no reports of an objective radiographic response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0397b640a8654b46769f9a79cbfb1490
https://doi.org/10.1159/000345938
https://doi.org/10.1159/000345938
Autor:
Domingo J. Tortonese, Valérie Hervieu, Christian Furth, G Ulrich, Mats Stridsberg, Ann M. Spungen, Viveka P. Jyotsna, Noura Benslama, Holger Amthauer, William A. Bauman, Michael F. La Fountaine, Ashok Kumar Jaryal, Larry K. Kvols, Andreas Pascher, Barbara Centeno, Stefano Severi, Dinu S. Chandran, Ulf Holmbäck, Takashi Kato, Lars Grimelius, Jonathan R. Strosberg, Brian Morse, Julien Bollard, Marianne Pavel, Alice Ambrosetti, Thomas Walter, Gilles Poncet, Malin Grönberg, Amy Christensen, Jean-Yves Scoazec, Lisa Bodei, Oriana Nanni, Jan Schiefer, Juri Ruf, Mirco Bartolomei, Paul E. Micevych, Ryosuke Kimura, Kiyofumi Asai, Lucila Leico Kagohara Elias, Giovanni Paganelli, Julie Townsend, Florian Lepinasse, David J. Hodson, Christopher M. Cirnigliaro, Fabiana C. Vilela, Masahiro Okouchi, Ortrud Kosiek, Jill M. Wecht, Siegfried Kropf, Bertram Wiedenmann, Martine Blanc, Kishore Kumar Deepak, Eva Tiensuu Janson, Anna Sarnelli, Colette Roche, Naotsuka Okayama, Naseer Ali, Satz Mengensatzproduktion, Timm Denecke, Carole Ferraro-Peyret, José Antunes-Rodrigues, Manuela Monti, Steven Kirshblum, Apostolos V. Tsolakis, Kenro Imaeda, Maddalena Sansovini, Takashi Joh, Alexandre Giusti-Paiva, Vita Saranga-Perry, Lucia Garaboldi, Druck Reinhardt Druck Basel, Christophe Couderc, Géraldine Gouysse
Publikováno v:
Neuroendocrinology. 97:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49603816dc69c90ce6a0dee570377f8c
https://doi.org/10.1159/000351602
https://doi.org/10.1159/000351602
Autor:
Pharis Mohideen, Bertram Wiedenmann, Kjell Öberg, Lowell Anthony, Yilong Zhang, Gareth Hughes, Thomas M. O'Dorisio, Wouter W de Herder, Larry K. Kvols, Ke Hu, Rudolf Arnold
Publikováno v:
Endocrine-Related Cancer, 19(5), 657-666. Bioscientifica Ltd
Pasireotide (SOM230) is a novel multireceptor-targeted somatostatin (sst) analog with high binding affinity for sst receptor subtype 1, 2, 3 (sst1,2,3) and sst5. Because of this binding profile, pasireotide may offer symptom control in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b240123dd31ca3d3b416c65cf90d7116
https://pure.eur.nl/en/publications/d713c8f2-fc46-4a36-893a-0412f99eb952
https://pure.eur.nl/en/publications/d713c8f2-fc46-4a36-893a-0412f99eb952
Autor:
Leslie M. Turner, Domenico Coppola, Evita Henderson-Jackson, Pamela J. Hodul, Dung-Tsa Chen, Naiel Hafez, Ardeshir Hakam, Timothy J. Yeatman, Aejaz Nasir, Jonathan R. Strosberg, James F. Helm, Marilyn M. Bui, Larry K. Kvols, Mokenge P. Malafa, Nelly A. Nasir
Publikováno v:
Pancreas. 40:627-633
Pancreatic endocrine tumors (PETs) are clinically challenging neoplasms. The incidence of these tumors in the United States is estimated to be 4 cases per million persons per year, with a 5-year survival of 44% to 71%.1–3 Based on the presence or a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e40f6ce5785bcc66eef76a7dfd0029
https://doi.org/10.1097/mpa.0b013e3182152bda
https://doi.org/10.1097/mpa.0b013e3182152bda
Autor:
Larry K. Kvols, Jessica St. Peter, Timothy J. Hobday, James C. Yao, Eric Van Cutsem, Bertram Wiedenmann, Thomas M. O'Dorisio, Tomas Haas, Matthew H. Kulke, Gabriele Luppi, Philippe Rougier, Eric Baudin, James A. Posey, David Lebwohl, Sakina Hoosen, Philippe Ruszniewski, Guillaume Cadiot, Manisha H. Shah, Catherine Lombard-Bohas
Publikováno v:
Journal of Clinical Oncology. 28:69-76
Purpose No established treatment exists for pancreatic neuroendocrine tumor (NET) progression after failure of chemotherapy. Everolimus (RAD001), an oral inhibitor of mammalian target of rapamycin, in combination with octreotide has demonstrated enco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338909eecb3f1a2bf2f0935d7bd7096b
https://doi.org/10.1200/jco.2009.24.2669
https://doi.org/10.1200/jco.2009.24.2669
Publikováno v:
Neuroendocrinology. 89:471-476
Background: Gastrointestinal neuroendocrine tumors (NETs) are heterogeneous neoplasms that vary in mortality according to location of primary tumor and stage of disease. Past analyses of survival suggest a trend towards improving longevity among pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6cfe14ce96750ac48e867fea2724e7
https://doi.org/10.1159/000197899
https://doi.org/10.1159/000197899